Integra LifeSciences (IART) Tops Q3 EPS by 1c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Integra LifeSciences Reports Third Quarter 2015 Financial Results
November 3, 2015 6:00 AM ESTRevenue Increased 14.6% to $226.4 Million with Adjusted EPS of $0.75
Adjusted Net Income Increased 15.1%
Raised Low End of Full Year 2015 Revenue and EPS Guidance
PLAINSBORO, N.J., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported its financial results for the third quarter ending September 30, 2015.
Highlights:Â
Third quarter revenue increased 14.6% over the prior year quarter to $226.4 million and organic revenue increased... More


